28.34USD+6.94%Mkt Cap: 450.40M USDP/E: 354.25Last update: 2026-05-22
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap450.40M USD
Enterprise Value197.04M USD
Revenue (TTM)71.10M USD
Gross Profit6.28M USD
Net Income (TTM)-6.12M USD
Revenue/Share5.243 USD
Last Price28.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0453961080
Valuation
P/E (Trailing)354.25
P/E (Forward)-11.39
PEG—
EV/EBITDA-14.68
EV/Revenue2.77
P/S5.92
P/B2.12
EPS (TTM)0.08
EPS (Forward)-2.33
52W Range
13.1357% of range39.71
52W High39.71 USD
52W Low13.13 USD
Profitability
Gross Margin8.84%
Oper. Margin-138.44%
EBITDA Margin-18.87%
Profit Margin-8.47%
ROE-2.96%
ROA-2.38%
Growth
Revenue Growth-12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-41.09M USD
CapEx (TTM)66.00K USD
FCF Margin—
FCF Yield—
Net Debt-224.11M USD
Net Debt/EBITDA16.70
Balance Sheet
Debt/Equity0.01
Current Ratio6.65
Quick Ratio6.49
Book Value/Sh12.50 USD
Cash/Share14.26 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateFeb 12, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)48.75 USD
Target Range40.00 USD – 62.00 USD
# Analysts4
Ownership
Shares Out.15.89M
Float7.52M
Insiders32.38%
Institutions60.30%
Short Interest
Short Ratio15.9d
Short % Float14.38%
Short % Out.9.80%
Shares Short1.56M
Short (prev mo.)1.53M
Technical
SMA 5028.54 (-0.7%)
SMA 20028.88 (-1.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)154.34K
Avg Vol (10d)105.57K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—